Telehealth Not Mentioned In WH Plan To Boost Substance Use Treatment

By Donna Haseley, Beth Wang / April 21, 2022 at 5:15 PM
The White House’s call Thursday (April 21) for federal agencies to increase access to substance use treatments as part of a broader strategy to address the opioid overdose epidemic makes no mention of allowing drugs to be prescribed via telehealth. The administration faces pressure from key lawmakers and stakeholders to continue COVID-19 public health emergency flexibilities that have allowed controlled substances, like the substance use disorder treatment buprenorphine, to be available through telehealth. The Senate Finance Committee pressed HHS Secretary...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.